Is a complete ABVX research report available?

No complete published report is available for ABIVAX Société Anonyme (ABVX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ABIVAX Société Anonyme (ABVX)

NASDAQ: ABVX · USD

$119

-5.39 (-4.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ABVX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.6B
Revenue (ttm)	5.7M
Net income (ttm)	-383M
EPS (ttm)	-$5.22
Shares out	79.3M
Volume	1,150,516
Beta	-0.21
Price target	$166	+39.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.7M
Net income (ttm): -383M
EPS (ttm): -$5.22
Market cap: 10.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ABVX indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

EUR

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001956827
Company name	ABIVAX Société Anonyme
Country	France
Country code	US
Cusip	00370M103
Employees	80
Employees Change	11%
Employees Change Percent	15.94
Enterprise value	$10.1B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
Isin	US00370M1036
Last refreshed	2026-07-30
Market cap	$10.6B
Market cap category	Large-Cap
Price	$119
Price currency	USD
Rev Per Employee	70,909.73x
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	ABVX
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.6%
EV Sales Forward	3,085.62x
EV/Sales	1,782.83x
FCF yield	-1.93%
P/B ratio	21.47x
P/S ratio	1,874.58x
PS Forward	3,244.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5,184.67%
EBITDA Margin	-5,160.98%
Gross margin	100%
Gross Profit	$5.7M
Gross Profit Growth	-59.82%
Gross Profit Growth Q	35.21%
Gross Profit Growth3 Y	3.13%
Net Income	$-383M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6,628.54%
Profit Per Employee	$-4.8M
ROA	-44.65
Roa5y	-37.56
ROCE	-52.34
ROE	-157.1
Roe5y	-198.1
ROIC	-56.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	78.59%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-59.82x
Revenue Growth Q	35.21x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	3.13x
Revenue Growth5 Y	222.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$630.9M
Cash	$566.8M
Current Assets	$588.7M
Current Liabilities	$71.4M
Debt	$39.4M
Debt Equity	$0.08
Equity	$495.3M
Interest Coverage	-9.58
Liabilities	$135.5M
Long Term Assets	$42.1M
Long Term Liabilities	$64.1M
Net Cash	$527.3M
Net Cash By Market Cap	$4.96
Net Debt Equity	$-1.06
Tangible Book Value	$466.5M
Tangible Book Value Per Share	$5.88
WACC	3.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.25
Net Working Capital	$-45.5M
Quick ratio	8.07
Working Capital	$520M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	78.52%
200-day SMA	116.5
50-day SMA	118.1
50-day SMA vs 200-day SMA	50over200
All Time High	148.8
All Time High Change	-20.15%
All Time High Date	2025-12-24
All Time Low	4.77
All Time Low Change	2,391.4%
All Time Low Date	2025-04-09
ATR	6.85
Beta	-0.21
Ch YTD	-11.88
High	125.2
High52	148.8
High52 Date	2025-12-24
High52ch	-20.15%
Low	118.2
Low52	66.11
Low52 Date	2025-07-29
Low52ch	79.76%
Ma50ch	0.63%
Premarket Change Percent	0.86
Premarket Price	$125
Premarket Volume	13,217
Price vs 200-day SMA	1.98%
RSI	43.16
RSI Monthly	68.55
RSI Weekly	51.37
Sharpe ratio	1.09x
Sortino ratio	1.76
Total Return	-16.25%
Tr YTD	-11.88
Tr1m	21.89%
Tr1w	-8.39%
Tr3m	8.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	10
Analyst Price Target Top	$162
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-4.91
Earnings Revenue Estimate	5,510,000x
Earnings Revenue Estimate Growth	-58.53x
Operating Income	$-294.1M
Operating margin	-5,184.6
Price target	$166
Price Target Change	$39.61
Price Target Change Top	$36.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,953,615%
Float Percent	92.01%
Net Borrowing	-61,740,107
Shares Insiders	0.58%
Shares Institutions	84.64%
Shares Out	79,291,188
Shares Qo Q	0.96%
Shares Yo Y	16.25%
Short Ratio	1.66
Short Shares	4.67

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-265.9M
Adjusted OCF	-265,773,139.3
Average Volume	1,374,432.9x
Bv Per Share	6.25
CAPEX	$-174,362
Ch1m	21.89
Ch1w	-8.39
Ch1y	78.52
Ch3m	8.16
Ch6m	4.26
Change	-4.34%
Change From Open	-4.85
Close	124.2
Days Gap	0.54
Depreciation Amortization	1,238,885.9
Dollar Volume	136,727,321.4
Earnings Date	2026-03-23
Earnings Time	amc
EBIT	$-292.6M
EBITDA	$-291.3M
EPS	$-5.22
F Score	3
FCF	$-204.8M
FCF EV Yield	-2.02x
FCF Per Share	$-2.58
Financing CF	640,167,185
Fiscal Year End	December
Founded	2,013
Goodwill	21,128,739.7
Income Tax	$7M
Investing CF	-10,123,371
Ipr	924.5
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-23
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	119.3
Ma150ch	-0.43%
Ma20	134.4
Ma20ch	-11.58%
Net CF	431,046,927
Next Earnings Date	2026-09-21
Open	124.9
Optionable	Yes
Position In Range	9.35
Post Close	118.8
Postmarket Change Percent	0.82
Postmarket Price	$120
Ppne	2,045,308.8
Pre Close	124.2
Price Date	2026-07-29
Ptbv Ratio	22.8
Relative Volume	0.84x
Revenue	5,672,778x
SBC By Revenue	1,083.7x
Share Based Comp	61,475,845
Tax By Revenue	123.5x
Tr6m	4.26%
Volume	1,150,516
Z Score	22.21

ABIVAX Société Anonyme (ABVX)

Coverage state: Market snapshot only — no published research

Generate the first ABVX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ABVX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ABVX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ABVX

Frequently asked questions